Research
Metabolic adaptation
Both groups experienced an improvement in cardiometabolic risk markers after 12 months.
Improvements in cardiometabolic health may accompany weight loss in postmenopausal women.
StrongSupportsmedium confidence
Both groups experienced an improvement in cardiometabolic risk markers.
Why this rating
The study design supports the reliability of the findings.
Source
Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use
Maria D. Hurtado et al. · Menopause The Journal of The North American Menopause Society · 2024
cohort · n=106Cited 26×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →